Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
NeuroOne Medical Technologies ( (NMTC) ) just unveiled an announcement.
On April 24, 2026, NeuroOne Medical Technologies announced that Chief Financial Officer Ronald McClurg intends to retire from his CFO role effective June 30, 2026, and will remain with the company as a Senior Advisor through December 31, 2026 to support a smooth transition under a Transition and Release Agreement. The board appointed current Chief Operating Officer Christopher Volker as CFO effective July 1, 2026, increasing his base salary to $350,000 and leveraging his extensive medtech, finance, and international expansion experience to strengthen the company’s leadership and financial oversight while maintaining continuity in its executive team.
The most recent analyst rating on (NMTC) stock is a Buy with a $8.00 price target. To see the full list of analyst forecasts on NeuroOne Medical Technologies stock, see the NMTC Stock Forecast page.
Spark’s Take on NMTC Stock
According to Spark, TipRanks’ AI Analyst, NMTC is a Neutral.
The score is primarily weighed down by persistent losses and significant negative free cash flow despite improved gross margins and low leverage. Technicals are mixed but trend weak given the stock is below major moving averages. Valuation support is limited due to negative earnings and no dividend. Earnings-call guidance and product/program progress provide some offset, but liquidity/runway concerns cap upside.
To see Spark’s full report on NMTC stock, click here.
More about NeuroOne Medical Technologies
NeuroOne Medical Technologies is a medical technology company focused on developing and commercializing minimally invasive, high-definition electrode technologies for neurological applications. Its products are aimed at improving surgical care and diagnostic capabilities in neurology, targeting hospitals, surgeons, and health systems involved in treating patients with brain-related disorders.
Average Trading Volume: 40,117
Technical Sentiment Signal: Strong Sell
Current Market Cap: $39.71M
Find detailed analytics on NMTC stock on TipRanks’ Stock Analysis page.